Skip to main content

Table 4 Laboratory test of 233 patients with COVID-19

From: Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness

Blood routine (Unit, Normal range) Total number N (%) Stat Total patient
N = 233(%)
Survival N = 205 (%) Deceased N = 28 (%)
Leucocyte (×109/L, range 3.5–9.5) 233 (100%) Increased 37 (15.9%) 20 (9.8%) 17 (60.7%)
Decreased 27 (11.6%) 25 (12.2%) 2 (7.1%)
Normal 169 (72.5%) 160 (78%) 9 (32.2%)
Neutrophil (×109/ L, range 1.8–6.3) 233 (100%) Increased 58 (24.9%) 36 (17.6%) 22 (78.6%)
Decreased 17 (7.3%) 16 (7.8%) 1 (3.6%)
Normal 130 (67.8%) 153 (74.6%) 5 (17.8%)
Lymphocyte (×109/ L, range 1.1–3.2) 233 (100%) Decreased 132 (57.6%) 110 (53.7%) 22 (78.6%)
Normal 101 (42.2%) 95 (46.3%) 6 (21.4%)
Platelet (×109/ L, range 125–450) 233 (100%) Increased 7 (3.1%) 6 (2.9%) 1 (3.6%)
Decreased 29 (12.4%) 23 (11.2%) 6 (21.4%)
Normal 197 (84.5%) 176 (85.9%) 21 (75%)
D-Dimer (mg/L; range < 0.55) 34 (15%) Increased 19 (55.9%) 12 (35.3%) 7 (20.6%)
Normal 15 (44.1%) 15 (64.7%) 0
ALT (IU/L, range 0–64) 202 (87%) Increased 22 (10.9%) 19 (10.6%) 3 (13.1%)
Normal 180 (89.1%) 160 (89.4%) 20 (86.9%)
AST (IU/L, range 8–40) 202 (87%) Increased 74 (36.6%) 57 (31.8%) 17 (73.9%)
Normal 128 (63.4%) 122 (68.2%) 6 (26.1%)
ALK.P (IU/L, range 25–320) 195 (84%) Increased 36 (18.5%) 30 (17.2%) 6 (28.6%)
Normal 159 (81.5%) 144 (82.8%) 15 (71.4%)
Total Bilirubin (mg/dL, range 0.4–1.3) 180 (77%) Increased 24 (13.3%) 19 (11.8%) 5 (26.3%)
Decreased 8 (4.4%) 8 (5.1%) 0
Normal 148 (82.3%) 134 (83.1%) 14 (73.7%)
Direct Bilirubin (mg/dL, range 0.1–0.3) 180 (77%) Increased 73 (40.6%) 62 (38.5%) 11 (57.9%)
Decreased 36 (20%) 33 (20.5%) 3 (15.7%)
Normal 71 (39.4%) 66 (41%) 5 (26.4%)
Bun (mg/dL, range 5–24) 225 (97%) Increased 59 (26.2%) 38 (19.1%) 21 (80.8%)
Normal 166 (73.8%) 161 (80.9%) 5 (19.2%)
Creatinine (mg/dL, range 0.5–1.4) 223 (96%) Increased 58 (26%) 40 (20.3%) 18 (69.2%)
Normal 165 (74%) 157 (79.7%) 8 (30.8%)
CPK (IU/L, range 12–160) 183 (79%) Increased 68 (37.2%) 57 (35%) 11 (55%)
Normal 115 (62.8%) 106 (65%) 9 (45%)
LDH (IU/L, range 140–280) 173 (74%) Increased 168 (97.1%) 151 (97.4%) 17 (94%)
Normal 5 (2.9%) 4 (2.6%) 1 (6%)
C-Reactive Protein (mg/L, 0.0–6.0) 233 (100%) Increased 206 (88.4%) 179 (87.3%) 27 (96.4%)
Normal 27 (11.6%) 26 (12.7%) 1 (3.6%)
ESR (mm/h, 2–22) 162 (70%) Increased 139 (85.8%) 124 (90.7%) 15 (100%)
Normal 23 (14.2%) 23 (9.3%) 0
NA (mEq/L, 135–145) 209 (90%) Increased 7 (3.4%) 3 (1.6%) 4 (16%)
Decreased 96 (45.9%) 85 (46.2%) 11 (44%)
Normal 106 (50.7%) 96 (52.2%) 10 (40%)
K (mEq/L, 3.5–5.5) 208 (90%) Increased 3 (1.4%) 0 3 (12%)
Decreased 49 (23.6%) 43 (23.5%) 6 (24%)
Normal 156 (75%) 140 (76.5%) 16 (64%)
NLR (index, < 5) 233 (100%) Increased 95 (40.8%) 69 (33.7%) 26 (92.9%)
Normal 138 (59.2%) 136 (66.3%) 2 (7.1%)
PLR (index, < 200) 233 (100%) Increased 104 (44.6%) 84 (40.9%) 20 (71.4%)
Normal 129 (55.4%) 121 (59.1%) 8 (28.6%)
SII (index, < 500) 233 (100%) Increased 159 (68.2%) 133 (64.9%) 26 (92.9%)
Normal 74 (31.8%) 72 (35.1%) 2 (7.1%)